Holen Sie sich die Stockscreener-App
6.97
0.43%
-0.03
Handel nachbörslich:
6.91
-0.06
-0.86%
Finanzdaten der Vanda Pharmaceuticals Inc-Aktie (VNDA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
1.70%
57.22
|
56.26 | 52.59 | 50.04 | 47.65 |
Operating Expenses
|
11.45%
97.57
|
87.54 | 91.09 | 91.07 | 58.65 |
| Benefits Costs and Expenses |
12.49%
95.22
|
84.65 | 87.48 | 87.41 | 53.90 |
| Costs And Expenses |
11.45%
97.57
|
87.54 | 91.09 | 91.07 | 58.65 |
| Operating Income/Loss |
28.99%
-40.35
|
-31.28 | -38.50 | -41.03 | -11.00 |
| Income/Loss From Continuing Operations Before Tax |
33.86%
-38.00
|
-28.39 | -34.89 | -37.37 | -6.244 |
| Income Tax Expense/Benefit, Deferred |
1,827%
103.19
|
-5.974 | -7.972 | -7.797 | -3.088 |
| Income Tax Expense/Benefit |
1,878%
103.19
|
-5.804 | -7.68 | -7.874 | -0.92 |
| Income/Loss From Continuing Operations After Tax |
525.11%
-141.19
|
-22.59 | -27.21 | -29.49 | -5.324 |
|
Net Income/Loss
|
525.11%
-141.19
|
-22.59 | -27.21 | -29.49 | -5.324 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.90%
0.0569
|
59.09 | 58.99 | 58.53 | 58.26 |
| Diluted Average Shares |
99.90%
0.0569
|
59.09 | 58.99 | 58.53 | 58.26 |
| Basic Earnings Per Share |
528.95%
-2.39
|
-0.38 | -0.46 | -0.50 | -0.09 |
| Diluted Earnings Per Share |
528.95%
-2.39
|
-0.38 | -0.46 | -0.50 | -0.09 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):